Product Description: OJT008 is an inhibitor of MtMetAP1c. OJT008 inhibits NiCl2- and CoCl2 activated MtMetAP1c with IC50s of 11 and 40 μM, respectively. OJT008 can used to study tuberculosis[1].
Applications: COVID-19-immunoregulation
Formula: C18H17ClN4
References: [1]Collins Onyenaka, et al. Anti-Tuberculosis Potential of OJT008 against Active and Multi-Drug-Resistant Mycobacterium Tuberculosis: In Silico and In Vitro Inhibition of Methionine Aminopeptidase. Int J Mol Sci. 2023, 24, 24.
CAS Number: 256370-29-3
Molecular Weight: 324.81
Compound Purity: 99.62
Research Area: Infection
Solubility: DMSO : 100 mg/mL (ultrasonic)
Target: Bacterial